Co-Authors
This is a "connection" page, showing publications co-authored by RICHARD E CHAMPLIN and HIROKI TORIKAI.
Connection Strength
0.575
-
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor. J Immunother. 2016 06; 39(5):205-17.
Score: 0.138
-
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application. Sci Rep. 2016 Feb 23; 6:21757.
Score: 0.135
-
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood. 2013 Aug 22; 122(8):1341-9.
Score: 0.112
-
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood. 2012 Jun 14; 119(24):5697-705.
Score: 0.104
-
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors. PLoS One. 2016; 11(8):e0159477.
Score: 0.035
-
Sleeping beauty system to redirect T-cell specificity for human applications. J Immunother. 2013 Feb; 36(2):112-23.
Score: 0.027
-
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells. Biomed Microdevices. 2010 Oct; 12(5):855-63.
Score: 0.023